1. A genitourinary cancer-specific scoring system for the prediction of survival in patients with bone metastasis: A retrospective analysis of prostate cancer, renal cell carcinoma, and urothelial Carcinoma;Owari;Anticancer Res.,2018
2. Miyake M, Owari T, Fujimoto K. Lack of evidence regarding bone metastases of genitourinary cancers: interventions by surgery, radiotherapy, and bone-targeted systemic therapy.Ann Transl Med. 7 (Suppl 3) (2019) S92. http://doi.org/10.21037/atm.2019.04.52.
3. Efficacy of stereotactic body radiotherapy in oligorecurrent and oligoprogressive castration resistant prostate cancer: New evidence from a multicentric study;Lucca;Br J. Cancer.,2017
4. Metastasectomy for visceral and skeletal oligorecurrent prostate cancer;Battaglia;World J. Urol.,2019
5. Clinical benefit of early treatment with bone-modifying agents for preventing skeletal-related events in patients with genitourinary cancer with bone metastasis: A multi-institutional retrospective study;Owari;Int. J. Urol.,2019